Procter & Gamble’s Q1 fiscal 2027 earnings, due before the open on October 22, anchor the near-even 51.5% trader consensus on an EPS beat. Analysts project $1.89 EPS, down about 5% year-over-year from $1.99, on roughly $22.8 billion revenue amid persistent input-cost inflation tied to geopolitical pressures and a projected $1 billion FY2027 profit headwind. PG has delivered seven consecutive EPS beats, including a modest 1.4% surprise in the prior quarter, yet revenue has frequently missed estimates while core margins face ongoing pressure. Recent analyst revisions have edged estimates slightly lower, and the company’s 1–3% organic sales guidance for the full year sits below prior expectations. The post-earnings call and any updated outlook will likely determine whether the modest historical outperformance or the cost and growth headwinds prevail.